Using Astrocyte Factors to Prevent Synaptic Alterations in Alzheimer’s Disease

Principal Investigator
Isabel Salas, PhD
The Salk Institute for Biological Studies
La Jolla, CA, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
September 01, 2020 - August 31, 2023
Grant ID
A20201645F
Mentor(s)
Nicola Allen, PhD, The Salk Institute for Biological Studies
Goals
The brain is the center of command of our bodies, controlling our motion, our behavior and our feelings. Its main components, the neurons, process information by making specialized connections (synapses) between them assisted by other important types of cells: the astrocytes. Alzheimer’s disease is associated with alterations in these connections. In this project I aim to restore the correct function of astrocytes, to rescue synaptic defects, in mouse models affected by Alzheimer disease and make a step further to the cure of this devastating disorder.
Summary
The brain is the center of command of our bodies. It controls our motion, our behavior, our feelings, our memories. Its main components, the neurons, process information by making fast connections, synapses, with each other. They are assisted by another important set of cells: the astrocytes. Astrocytes are cells with a star-shape that can contact more than one thousand different synapses. Their presence at the synapse is essential for correct transmission of information. In Alzheimer’s disease these synapses are lost, but we still do not fully understand why and how. In this project, I will study if changes to astrocytes in Alzheimer’s disease are responsible for the loss of synapses. To study this, I am using mice that have mutations in genes associated with Alzheimer’s disease, and that develop symptoms of the disease. Using these mice, I found that in Alzheimer’s disease astrocytes produce more levels of a factor, Glypican 5, important for synaptic function. I will test if this increase in Glypican 5 is toxic for synapses and is contributing to their loss in Alzheimer’s disease. I will do this by decreasing the levels of Glypican 5 in astrocytes from mice affected by Alzheimer’s disease. I expect that this reduction will restore the correct function of the synapses. These discoveries may have important implications for Alzheimer’s disease, by identifying a new way to prevent synapse loss and take a step further to the cure of this devastating disease.
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Dong Kyu Kim, PhD
Current Organization
University of California
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Dong Kyu Kim, PhD
Current Organization
University of California
Alzheimer's Disease Research
Cancer-Like Metabolic Changes in Alzheimer's Disease Neurons
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Jerome Mertens, PhD
Current Organization
University of California, San Diego
Cancer-Like Metabolic Changes in Alzheimer's Disease Neurons
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Jerome Mertens, PhD
Current Organization
University of California, San Diego